Why Physician Oversight Doesn’t Mean Higher Prices
There is a persistent worry in the peptide community that physician involvement will make everything more expensive and less accessible. It’s understandable. Healthcare in this country has a long track record of adding cost and friction without adding proportional value. The concern is reasonable on its face.
But it rests on an assumption worth examining: that the physician’s role is to add a layer on top of something that was already working fine. That’s not what physician oversight means at Ivim, and it’s not how our clinical team approaches it.
Dr. Jessica Duncan, our Chief Medical Officer, is direct about the incentive structure: ” My job is to figure out what’s right for each patient. I don’t earn a commission based on what I prescribe. ” A physician who earns nothing from recommending a particular peptide is the only person in the transaction whose recommendation you can actually trust. There is no upside for a physician with no financial stake to prescribe something that isn’t right for you. That’sthe structural difference between a clinician and a seller.
What physician oversight actually delivers is specificity. The right compound for your situation, at the right dose, cycled correctly, sourced from a pharmacy that meets regulatory standards. That is what a clinical protocol looks like. The alternative is not a cheaper version of the same thing. It is a guess based on someone else’s experience, sourced from a supply chain you cannot verify, with no one monitoring whether you’re responding appropriately.
There is also a sourcing reality that most people outside the clinical space don’t think about. “Not all primary care providers have access to pharmacies that would be making and manufacturing peptides,” Dr. Duncan notes. “We source our pharmacies very specifically — we make sure that they meet all the regulatory guidelines and have gone through all the paces they need to go through so we can trust that they are a safe source.” Ivim built those pharmacy relationships deliberately. They are part of what you’re accessing when you come to us.
Access to pharmaceutical-grade compounds from vetted sources is not a luxury feature. It’s the baseline for a protocol you can actually rely on. The price of skipping it is not a discount. It’s uncertainty about what you’re taking.
Frequently Asked Questions
What does FDA-registered compounding pharmacy mean?
Compounding pharmacies that operate under FDA oversight are required to meet standards for purity, potency, and sterility. They are subject to inspection and must demonstrate that their manufacturing processes are controlled and documented. This is meaningfully different from gray-market sources, which operate outside that framework and offer no comparable guarantee of what’s in the product.
How does Ivim select its pharmacy partners?
Ivim evaluates pharmacies specifically against regulatory compliance and quality standards before establishing a partnership. The sourcing decision is clinical, not transactional. Our physicians need to trust what they’re prescribing — and that trust has to be grounded in verification, not assumption.
Do I need insurance for peptide therapy at Ivim?
Peptide therapy is typically not covered by insurance because the compounds are not FDA-approved for these specific uses. Ivim’s pricing reflects the cost of the clinical evaluation, the compound, and ongoing monitoring. For specific pricing information, please visit our website or contact our patient team directly.
What’s included in the clinical evaluation?
A clinical evaluation at Ivim covers your full health history, current medications, and wellness goals. Your physician will assess which peptides are appropriate for your situation, discuss risks and benefits honestly, and outline a protocol that reflects your specific needs. Follow-up is built in — the evaluation is the start of the clinical relationship, not a one-time gate.
